Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

analgin 500mg

Philippines - English - FDA (Food And Drug Administration)

metro drug inc.; distributor: metro drug inc. - rasagiline (as mesilate) - tablet - 1 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - rasagiline - tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - rasagiline - tablet - 1mg

Philippines - English - FDA (Food And Drug Administration)

metro drug, inc.; distributor: metro drug, inc. - rasagiline (as mesylate) - tablet - 1 mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - rasagiline mesylate - eq. rasagiline 1 mg - tablet - rasagiline

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - hydralazine hydrochloride 20 mg/ml - powder for injection - 20 mg/ml - active: hydralazine hydrochloride 20 mg/ml - for the treatment of chronic congestive heart failure as adjunct to long-acting nitrates, digitalis and other positive-inotropic agents and/or diuretics.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

plumbline life sciences, inc - synthetic porcine ghrh encoding plasmid - parenteral liquid/solution/suspension - synthetic porcine ghrh encoding plasmid hormone-gonadotrophin active 2.5 mg/ml - endocrine system - pig sow (female) | female pig - increase weaning

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - rasagiline tartrate - tablets - 1 milligram - rasagiline - anti-parkinson-drugs, monoamine oxidase -b inhibitors - rasagiline accord is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - rasagiline tartrate - parkinson disease - anti-parkinson drugs - rasagiline mylan is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.